XML 15 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net sales $ 532,550 $ 483,400 $ 1,013,029 $ 926,314
Cost of goods sold (excluding amortization expense - See Note 13) 343,346 311,677 647,090 593,331
Gross profit 189,204 171,723 365,939 332,983
Selling, general and administrative expenses 140,485 126,600 276,250 245,646
Impairment charges 0 88,840 0 88,840
Restructuring and related charges, net 8,116 8,793 15,497 23,383
Operating income (loss) 40,603 (52,510) 74,192 (24,886)
Other income (expense), net 406 (653) 383 (1,362)
Interest expense (9,873) (12,779) (19,752) (22,324)
Income (loss) before taxes and equity in net income of associated companies 31,136 (65,942) 54,823 (48,572)
Taxes on income before equity in net income of associated companies 11,172 5,472 18,317 13,014
Income (loss) before equity in net income of associated companies 19,964 (71,414) 36,506 (61,586)
Equity in net income of associated companies 6,849 4,851 10,049 7,940
Net income (loss) 26,813 (66,563) 46,555 (53,646)
Less: Net (loss) income attributable to noncontrolling interest (22) 17 51 12
Net income (loss) attributable to Quaker Chemical Corporation $ 26,835 $ (66,580) $ 46,504 $ (53,658)
Per share data:        
Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) $ 1.56 $ (3.78) $ 2.69 $ (3.04)
Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) 1.55 (3.78) 2.68 (3.04)
Dividends declared (in dollars per share) $ 0.508 $ 0.485 $ 1.016 $ 0.970